CClinicalTrials.gg
TerminatedNCT01284075Updated Aug 22, 2014

The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery

An interventional study of Guided imagery and music therapy and White Noise in Ovarian Cancer and Uterine Cancer, sponsored by University of Minnesota. Terminated at 1 site in United States. Open to female participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2014-08-22.

Sponsored by University of Minnesota · Not applicable, Interventional, and Supportive care

Why this study was terminated
Low accrual
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
19 Years and older
Sex
Female
01

Study summary

This pilot study will be a prospective, randomized trial which will take place at the University of Minnesota Medical Center (UMMC). Eligible patients will be identified at the time of their first clinic visit. If selected to be involved in the study, the patients will be randomized to one of three different groups: a Guided Imagery and Music therapy group (GIMT) or one of two control groups.

Read the detailed description

The GIMT group will undergo a standardized regimen of peri-operative guided imagery and music therapy guided by CDs. As there are no studies which discuss whether the act of listening to any therapy will affect outcomes, we will also explore whether white noise can affect outcomes as well. Therefore, one control group (WN) will abide by the same regimen and will listen to a CD with white noise; the other control group (CP) will have no intervention at all and will follow our current peri-operative procedures.

02

Conditions studied

  • Ovarian Cancer
  • Uterine Cancer

Browse trials for

03

In context

Uterine Neoplasms

255 studies on the registry are indexed under Uterine Neoplasms; 64 are open to participants now.

This study's enrollment of 10 is below the median of 49 across 181 interventional studies indexed under Uterine Neoplasms.

Browse Uterine Neoplasms studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Subjects will include women who are being seen at the Women's Health Center by the Gynecological Oncology group at the University of Minnesota (UMMC). These women will be considered for inclusion based on their projected surgery: exploratory laparotomy. Subjects will have to have their surgery at the UMMC within 1 month of their clinic visit. Patients may be undergoing surgery for either known cancer (ovarian or uterine) or high suspicion for malignancy.

Exclusion criteria

Exclusion Criteria:

  • \< 19 years old
  • pregnant
  • undergoing a procedure other than laparotomy
  • scheduled to be discharged the same day of surgery
  • chronic narcotic pain medication users
  • if they are currently using or planning on using other complementary alternative medicine (CAM) therapies prior to or after surgery.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Guided Imagery and Music therapy group (GIMT)

    Participants will undergo a standardized regimen of peri-operative guided imagery and music therapy guided by CDs (compact disc). The peri-operative regimen will include: listening to the CD while in the pre-operative holding area, listening to the CD during the procedure; listening to the CD after the procedure beginning on the evening of post-operative day (POD)#0 and continuing twice a day until POD#3.

    Behavioral: Guided imagery and music therapy

  • Active comparator
    White Noise Group (WN)

    Control group (WN) will listen to a CD with white noise. Participants' regimen will include: listening to the CD while in the pre-operative holding area, listening to the CD during the procedure; listening to the CD after the procedure beginning on the evening of post-operative day (POD)#0 and continuing twice a day until POD#3.

    Behavioral: White Noise

  • Active comparator
    No Interventions Group (CP)

    Control group (CP) will have no intervention at all and will follow our current peri-operative procedures.

    Other: No intervention

Interventions

  • BehavioralGuided imagery and music therapy

    Participants will undergo a standardized regimen of peri-operative guided imagery and music therapy guided by CDs (compact disc). The peri-operative regimen will include: listening to the CD while in the pre-operative holding area, listening to the CD during the procedure; listening to the CD after the procedure beginning on the evening of post-operative day (POD)#0 and continuing twice a day until POD#3.

  • BehavioralWhite Noise

    Control group (WN) will listen to a CD with white noise. Participants' regimen will include: listening to the CD while in the pre-operative holding area, listening to the CD during the procedure; listening to the CD after the procedure beginning on the evening of post-operative day (POD)#0 and continuing twice a day until POD#3.

  • OtherNo intervention

    Control group (CP) will have no intervention at all and will follow our current peri-operative procedures.

06

What researchers measure

Primary outcomes

  1. Change in Mean Pain Score

    Determined by using a Visual Analog Pain Scale (VAS)- A Visual Analogue Scale (VAS) for pain is a horizontal line 100 mm in length with the left end labeled 'No pain' and the right end labeled 'Very severe pain'. The subject marks a point on the line that represents their perception of their current state. The VAS score is determined by measuring the distance from the left end of the line to the point on the line marked by the subject. The range of possible values for this pain score is 0 to 100 millimetres.

    Time frame: From Admission through 4 Weeks Post Surgery

Secondary outcomes

  1. Use of Pain Medication

    List of pain medications and number of times administered.

    Time frame: From Admission to 4 Weeks Post Surgery

  2. Use of Anti-Nausea Medications

    List of anti-emetic medications and number of times administered

    Time frame: From Admission to 4 Weeks Post Surgery

  3. Mean Change in Patient Quality of Life Score

    Using the Functional Assessment of Cancer Therapy General Scale (FACT-G) for patients with cancer (consisting of a four-factor structure - "Physical well-being", "Social-family well-being", "Functional well-being" and "Emotional well-being"). Five response choices range from "not at all" to "very much".

    Time frame: From Admission to 4 Weeks Post Surgery

  4. Average Number of Days Hospitalized

    Time frame: From Admission through 4 Weeks Post Surgery

  5. Hospital Readmission Rates

    Time frame: From Admission Through 4 Weeks Post Surgery

  6. Change in Profile of Mood States (POMS)

    The Profile of Mood States (POMS) original scale contains 65 self-report items using the 5-point Likert Scale. Participants can choose from 0 (not at all) to 4 (extremely). The test takes approximately 3 to 7 minutes for healthy participants, and longer for the physically ill.

    Time frame: From Admission Through 4 Weeks Post Surgery

  7. Length of Hospital Stay (Days)

    Time frame: From Admission through 4 Weeks Post Surgery

07

Study locations

1 site
  • Masonic Cancer Center, University of Minnesota
    Minneapolis, Minnesota 55455, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01284075
Lead sponsor
University of Minnesota
Responsible party
Sponsor
First posted
Jan 26, 2011
Start date
Apr 2010
Primary completion
Apr 2013
Completion
Apr 2013
Last update
Aug 22, 2014

Study contacts

Amy Jonson, MD
principal investigator · Masonic Cancer Center, University of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion